The Record header image

Forward to a friend  |  Subscribe  |  The Record Archive  |  Contacts  |  bcbsm.com  |  Print this article

November 2023

Requirements and codes changed for some medical benefit drugs

As part of our efforts to encourage appropriate use of high-cost medications covered under the medical benefit, we recently added requirements for some medical benefit drugs. Also, the Centers for Medicare & Medicaid Services assigned some drugs new HCPCS codes. The changes went into effect on various dates in July, August and September.

Changes in requirements

For Blue Cross Blue Shield of Michigan commercial and Blue Care Network commercial members, we added prior authorization requirements for the following:

HCPCS code

Brand name

Generic name

J3590**

Elevidys

Delandistrogene moxeparvovec-rokl

J3590**

Eylea® HD

Aflibercept

J3590**

Izervay™

Avacincaptad pegol

J3590**

Lantidra™

Donislecel-jujn

J3590**

Roctavian™

Waloctocogene roxaparvovec-rvox

J3590**

Rystiggo®

(Rozanolixizumab-noli)

J3590**

Tyruko®

Natalizumab-sztn

J3590**

Veopoz™

Pozelimab-bbfg

J3590**

Vyvgart® Hytrulo

(Efgartigimod alfa and hyaluronidase-qvfc)

For Medicare Plus Blue℠ and BCN Advantage℠ members, we added prior authorization requirements for the following:

HCPCS code

Brand name

Generic name

For dates of service on or after

J3590**

Elevidys

Delandistrogene moxeparvovec-rokl

July 10, 2023

J3590**

Roctavian™

Valoctocogene roxaparvovec-rvox

July 10, 2023

J3590**

Rystiggo®

Rozanolixizumab-noli

July 10, 2023

J3490**

Vyvgart® Hytrulo

Efgartigimod alfa and hyaluronidase-qvfc

July 10, 2023

J3590**

Qalsody™

Tofersen

Aug. 1, 2023

J3590**

Elfabrio®

Pegunigalsidase alfa-iwxj

Aug. 14, 2023

J3590**

Vyjuvek™

Beremagene geperpavec-svdt

Aug. 14, 2023

J3590**

Veopoz™

Pozelimab-bbfg

Sept. 1, 2023

Code changes

The table below shows HCPCS code changes that were effective July 1, 2023, (unless otherwise noted) for medical benefit drugs we manage.

New HCPCS code

Brand name

Generic name

J1440

Rebyota™

Fecal microbiota, live-jslm

J1576

Panzyga®

Immune globulin Intravenous (human) – ifas 10%

J9381

Tzield®

Teplizumab-mzwv

J9029

Adstiladrin®

Nadofaragene firadenovec-vncg

J0174 (effective July 6, 2023)

Leqembi®

Lecanemab-irmb

Drug lists

For additional details, see the following drug lists:

These lists are also available on the following pages of the ereferrals.bcbsm.com website:

More information about these requirements

We communicated these changes previously through provider alerts. Those alerts contain additional details.

You can view the provider alerts on ereferrals.bcbsm.com and on our Provider Resources site, which is accessible through our provider portal (availity.com).***

More information for Blue Cross commercial groups

For Blue Cross commercial groups, authorization requirements apply only to groups that participate in the standard commercial Medical Drug Prior Authorization Program for drugs administered under the medical benefit. To determine whether a group participates in the prior authorization program, see the Specialty Pharmacy Prior Authorization Master Opt-in/out Group list. A link to this list is also available on the Blue Cross Medical Benefit Drugs page of the ereferrals.bcbsm.com website.

Note: Blue Cross and Blue Shield Federal Employee Program® members and UAW Retiree Medical Benefits Trust (non-Medicare) members don't participate in the standard prior authorization program

Reminder

An authorization approval isn’t a guarantee of payment. As always, health care providers need to verify eligibility and benefits for members.

Availity® is an independent company that contracts with Blue Cross Blue Shield of Michigan and Blue Care Network to offer provider portal and electronic data interchange services.

**May be assigned a unique code in the future.

***Blue Cross Blue Shield of Michigan and Blue Care Network doesn’t own or control this website.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2022 American Medical Association. All rights reserved.